Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and...
Salbutamol is indicated for (i) the symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, reversible obstructive airway disease, and other chronic bronchopulmonary disorders in which bronchospasm is a complicating factor, and/or (ii) the acute prophylaxis against exercise-induced bronchospasm and other stimuli known t...
Royal Hospital, Muscat, Oman
CHU Sainte-Justine, Montréal, Quebec, Canada
Hatyai Hospital, Hat Yai, Songkhla, Thailand
Medical University of Warsaw, Warsaw, Poland
Brigham and Women's Hospital, Boston, Massachusetts, United States
Aleppo University Hospital, Aleppo, Aleppo Provice, Syrian Arab Republic
Environmental Physiology Laboratory, Vancouver, British Columbia, Canada
Rabia Asif, Karachi, Sindh, Pakistan
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.